Latest News about DEA Cannabis
Recent news which mentions DEA Cannabis
DEA Faces Lawsuit Alleging Bias In Marijuana Rescheduling Process
November 12, 2024
From Benzinga
Congressman Blumenauer Slams DEA For Postponing Marijuana Rescheduling, Places Hope In Soon-To-Be President Harris
August 28, 2024
From Benzinga
DEA's Call For Public Input On Cannabis Garnered 42,000 Comments: Majority Want Total Legalization Or Rescheduling
July 24, 2024
From Benzinga
Denver: Veteran Cannabis City Speaks Out On Rescheduling, 'We Have A Lot Of Expertise To Offer'
July 18, 2024
Tickers
NEWS
From Benzinga
Former FDA Agent Says Big Pharma Not Likely To Get Involved In Cannabis Industry After Rescheduling
May 03, 2024
From Benzinga
Biden Admin Official Denies Cannabis Shift Rumors, Gen-Zers Say They Can Drive Stoned, FLA Caps Weed Strength & More Updates
February 07, 2024
From Benzinga
GOP Congressman Says 'FDA Ignored Marijuana's Risks' In Rescheduling Proposal, Argues Agency's Credibility 'Challenged By COVID'
February 02, 2024
Tickers
NEWS
From Benzinga
Senator Gillibrand Urges Biden Administration To Deschedule Marijuana: 'It's A Medical Issue And It's A Public Safety Issue'
January 29, 2024
Tickers
NEWS
From Benzinga
Federal Agency To Release All Redacted Documents Related To Cannabis Rescheduling Memo, Amid Litigation
January 12, 2024
Tickers
NEWS
From Benzinga
DEA Raises THC, Psilocybin And DMT Production Quotas For Scientific Research Purposes
January 02, 2024
From Benzinga
DEA Warns Pharmacies Selling Medical Marijuana In Georgia That THC Oil Is Illegal To Dispense
December 07, 2023
From Benzinga
University Of Mississippi Launches Cannabis, Dietary Supplements Program
November 10, 2023
From Benzinga
DEA Vs. HHS: Who Is To Blame For Cannabis Still Being A Schedule 1 Drug?
December 06, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.